A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/114, 167/139
A61K 39/395 (2006.01) A61K 35/14 (2006.01) C07K 16/28 (2006.01) C12N 5/06 (2006.01) A61K 35/12 (2006.01)
Patent
CA 2034769
PATENT 6757 ABSTRACT OF THE DISCLOSURE The development of cytolytic activity of lymphocytes can be potentiated by contacting the lymphocytes with antibody reactive with CD28 receptor, such as 9.3 monoclonal antibody. The cytolytic activity thus potentiated is CD3 heteroconjugate-independent since targeting with a CD3 anti-target compound is not required. The development of cytolytic activity can be further potentiated by also contacting the lymphocytes with antibody reactive with anti-CD2 antibody or immobilized antibody to the CD3 receptor, or by also contacting the lymphocytes with interleukin-2. The CD28 receptor may be aggregated on the surface of the lymphocytes, as by crosslinking the antibody reactive to it on the surface of the lymphocytes. This crosslinking can be by the use of a second antibody reactive with the anti-CD28 antibody. Another aspect of the present invention is a method of adoptive therapy for treating cancer in a subject comprising the steps of: (1) contacting lymphocytes in vitro with an antibody reactive with CD28 receptor to potentiate the development of cytolytic activity of the lymphocytes to produce lymphocytes having cytolytic activity that is CD3 heteroconjugate independent; and (2) introducing the cytolytic lymphocytes into a subject to kill cancer cells. 6757APL.2
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Anti-cd28 antibody for potentiating cytolytic activity of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-cd28 antibody for potentiating cytolytic activity of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cd28 antibody for potentiating cytolytic activity of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1685762